(137 micrograms + 50 micrograms)/dose nasal spray, suspension
Azelastini hydrochloridum + Fluticasoni propionas
used for
Azelastine hydrochloride + Fluticasone propionate Teva contains two active substances: azelastine hydrochloride and fluticasone propionate.
Azelastine hydrochloride + Fluticasone propionate Teva is used to relieve symptoms of moderate to severe seasonal and perennial allergic rhinitis, if the use of other nasal sprays containing only an antihistamine or a corticosteroid is considered insufficient.
Seasonal and perennial allergic rhinitis is a type of allergic reaction to substances such as: plant pollen (hay fever), house dust mites, mold spores, dust or pet dander.
Azelastine hydrochloride + Fluticasone propionate Teva relieves allergy symptoms, such as: nasal discharge, postnasal drip, sneezing and itching or a feeling of nasal congestion.
propionate Teva
Before starting treatment with Azelastine hydrochloride + Fluticasone propionate Teva, the patient should discuss with their doctor or pharmacist if:
In these cases, the doctor will decide whether Azelastine hydrochloride + Fluticasone propionate Teva can be used.
It is essential to use the medicine in the dose prescribed below in section 3 or as recommended by the doctor.
Using nasal corticosteroids in higher doses than recommended may cause adrenal gland problems, which can lead to weight loss, fatigue, muscle weakness, low blood sugar, increased salt requirements, joint pain, depression, and darker skin pigmentation. In such cases, the doctor may prescribe another medicine during periods of stress or scheduled surgery.
To avoid adrenal gland problems, the doctor may recommend using the medicine in the smallest effective dose to control the symptoms of allergic rhinitis.
In children and adolescents, long-term use of nasal corticosteroids (such as Azelastine hydrochloride + Fluticasone propionate Teva) may slow down growth rates. The doctor will regularly check the child's growth and ensure they are using the medicine in the lowest effective dose.
If the patient experiences blurred vision or other vision problems, they should consult their doctor.
If the patient is unsure whether any of the above situations apply to them, they should consult their doctor or pharmacist before using Azelastine hydrochloride + Fluticasone propionate Teva.
This medicine is not recommended for children under 12 years of age.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, including those available without a prescription.
Some medicines may enhance the effect of Azelastine hydrochloride + Fluticasone propionate Teva nasal spray, and the doctor may recommend close monitoring if the patient is taking such medicines (including certain HIV medicines: ritonavir, cobicistat, and antifungal medicines: ketoconazole). Do not use Azelastine hydrochloride + Fluticasone propionate Teva if the patient is taking sedatives or central nervous system depressants.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Azelastine hydrochloride + Fluticasone propionate Teva has a minor influence on the ability to drive and use machines.
Very rarely, drowsiness, weakness, or dizziness may occur, which may be caused by the disease itself or the use of Azelastine hydrochloride + Fluticasone propionate Teva. In such cases, the patient should not drive or operate machinery. They should be aware that drinking alcohol may enhance this effect.
This medicine contains 14 micrograms of benzalkonium chloride per spray. Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long time.
If the patient experiences discomfort during use, they should inform their doctor or pharmacist.
This medicine should always be used as directed by the doctor or pharmacist. If the patient has any doubts, they should consult their doctor or pharmacist.
For the treatment to be effective, Azelastine hydrochloride + Fluticasone propionate Teva must be used regularly.
Avoid contact with the eyes.
Nasal spray.
Read the instructions below carefully and use the medicine only as directed.
Figure 1
Figure 2
Figure 3
Figure 4
It is essential to use the dose prescribed by the doctor. The patient should only use the dose recommended by the doctor.
Azelastine hydrochloride + Fluticasone propionate Teva can be used long-term. The duration of treatment should correspond to the period during which allergy symptoms occur.
In the event of an overdose of the nasal spray, there is a low risk of complications. The patient should consult their doctor if they are concerned or have been using a higher dose than recommended for an extended period. If someone, especially a child, accidentally ingests Azelastine hydrochloride + Fluticasone propionate Teva, they should immediately contact a doctor or the nearest hospital emergency department.
The patient should use the nasal spray as soon as they remember, and then use the next dose at the usual time. They should not use a double dose to make up for a missed dose.
The patient should not stop using Azelastine hydrochloride + Fluticasone propionate Teva without consulting their doctor, as this may lead to a lack of treatment effectiveness.
If the patient has any further doubts about using this medicine, they should consult their doctor or pharmacist.
Like all medicines, Azelastine hydrochloride + Fluticasone propionate Teva can cause side effects, although not everybody gets them.
eye redness and pain. These side effects have been reported after long-term use of nasal sprays containing fluticasone propionate.
In the event of using the medicine in high doses for a long time, systemic side effects may occur (side effects affecting the entire body). The likelihood of their occurrence is much lower when using nasal corticosteroids than during treatment with oral corticosteroids. These side effects may vary between patients and after using different corticosteroid medicines (see section 2).
Nasal corticosteroids may affect the normal production of hormones in the body, especially when used for a long time in high doses. In children and adolescents, these side effects may cause growth retardation.
In rare cases, a decrease in bone density (osteoporosis) has been observed when corticosteroids were used nasally for a long time.
If the patient experiences any side effects, including those not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the label and carton after EXP. The expiry date refers to the last day of the month stated.
Do not store in the refrigerator or freeze.
Shelf life after first opening the bottle: The unused medicine should be discarded 6 months after opening the nasal spray.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
The active substances of the medicine are azelastine hydrochloride and fluticasone propionate.
Each mL of suspension contains 1,000 micrograms of azelastine hydrochloride and 365 micrograms of fluticasone propionate.
After each actuation of the pump (0.14 g), 137 micrograms of azelastine hydrochloride (corresponding to 125 micrograms of azelastine) and 50 micrograms of fluticasone propionate are released.
The other ingredients are disodium edetate, glycerol (E 422), microcrystalline cellulose, sodium carmellose, polysorbate 80, benzalkonium chloride, phenylethyl alcohol, and water for injections.
Azelastine hydrochloride + Fluticasone propionate Teva is a white nasal spray suspension, available in a brown glass bottle with a pump sprayer, nasal applicator, and protective cap.
Each bottle with a capacity of 25 mL contains 23 g of nasal spray suspension (at least 120 doses).
Each pack contains one bottle with 23 g of nasal spray suspension or a multipack containing three bottles, each containing 23 g of nasal spray suspension.
Not all pack sizes may be marketed.
Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands
Teva Czech Industries s.r.o.
Ostravská 305/29
747 70 Opava - Komárov
Czech Republic
Teva Pharmaceuticals Polska Sp. z o.o.
tel. +48 22 345 93 00
Belgium:
Riniforce, 137 microgram/50 microgram/dose nasal spray, suspension
Riniforce 137 microgrammes/50 microgrammes/dose suspension pour pulvérisation nasale
Riniforce 137 Mikrogramm/50 Mikrogramm/Sprühstoß Nasenspray, Suspension
Estonia:
AzoFix 137 mikrogrammi/50 mikrogrammi
Lithuania:
Dunoase 137 mikrogramai/50 mikrogramų/ spūsnyje nosies purškalas (suspensija)
Latvia:
AzoFix 137 mikrogrami/50 mikrogrami izsmidzinājumā deguna aerosols, suspensija
Germany:
AzeFlut-ratiopharm 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
Poland:
Azelastine hydrochloride + Fluticasone propionate Teva
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.